GreenGrahi founders Siddharth Sharma and Shivali Sugand
Venture capital firm Avaana Capital has led the seed funding of ₹32 crore (approximately $3.8 million) in GreenGrahi, an insect protein start-up. The round also saw participation from existing investors Huddle Ventures, Campus Fund, Blume Founders Fund, and leading angel investors including Nitin Sharma (Nexus Ventures), Anchit Gupta (Samara Capital), David Chen (Equilibrium Capital), and Sameer Brij Verma (Northpoint Capital).
Founded by Shivali Sugand and Siddharth Sharma, GreenGrahi is developing a differentiated insect biotechnology platform powered by the Black Soldier Fly (BSF) and its unique microbiome. The company produces high-performance insect proteins, functional oils, and hydrolysates tailored for aquaculture, poultry, and pets — designed to deliver superior nutrition, better digestibility, and greater price stability compared to conventional inputs like fishmeal and soya. Alongside, GreenGrahi has built a new generation of biological agri-inputs — including biofertilizers, biostimulants and biopesticides — that help improve soil health, boost crop resilience and yield, and reduce the need for chemical fertilisers and pesticides.
“GreenGrahi is creating category-shaping innovation in the food and agri-tech pace,” said Shruti Srivastava, Investment Director at Avaana Capital. “Their proprietary insect biotechnology and bioprocessing platform enables the production of high-performance, cost-efficient ingredients at scale — helping build resilient food supply chains for global food security through science-backed, market-ready solutions.”
“We’re excited to double down on our investment in GreenGrahi as they lead India’s journey in the insect bio manufacturing industry. The timing is right, the demand is real, and India needed a bold, full-stack operator to build for both local and global markets. We’re proud to back the team as they launch the country’s first and largest BSF bio-factory, and look forward to their continued progress in market adoption and measurable impact.”, said Ishaan Khosla, Partner at Huddle Ventures
GreenGrahi’s proprietary biomanufacturing system ensures consistent quality and high conversion efficiency, enabling price points that unlock mass-market applicability, moving insect protein and biologicals beyond niche use cases.
“As wild fish stocks continue to decline and protein demand rises, the pressure on aquafeed and livestock inputs is only going to grow,” said Siddharth Sharma, Co-Founder of GreenGrahi. “We’re building a platform that makes high-quality, science-driven feed and agri-inputs accessible, affordable and scalable for global markets.”
The ₹32 crore raise will be used to build India’s largest BSF bio-factory, capable of processing 150 tonnes of feedstock daily. The company will also expand its scientific team and enter global markets, including the US, the UK and the EU. By combining cutting-edge microbiome science, bioengineering, and a strong manufacturing backbone, GreenGrahi is creating a reliable, cost-effective alternative to some of the most strained links in today’s food supply chain — from protein to crop inputs — while unlocking more value from underused agri-residues.
Published on April 24, 2025
GreenGrahi founders Siddharth Sharma and Shivali Sugand
Venture capital firm Avaana Capital has led the seed funding of ₹32 crore (approximately $3.8 million) in GreenGrahi, an insect protein start-up. The round also saw participation from existing investors Huddle Ventures, Campus Fund, Blume Founders Fund, and leading angel investors including Nitin Sharma (Nexus Ventures), Anchit Gupta (Samara Capital), David Chen (Equilibrium Capital), and Sameer Brij Verma (Northpoint Capital).
Founded by Shivali Sugand and Siddharth Sharma, GreenGrahi is developing a differentiated insect biotechnology platform powered by the Black Soldier Fly (BSF) and its unique microbiome. The company produces high-performance insect proteins, functional oils, and hydrolysates tailored for aquaculture, poultry, and pets — designed to deliver superior nutrition, better digestibility, and greater price stability compared to conventional inputs like fishmeal and soya. Alongside, GreenGrahi has built a new generation of biological agri-inputs — including biofertilizers, biostimulants and biopesticides — that help improve soil health, boost crop resilience and yield, and reduce the need for chemical fertilisers and pesticides.
“GreenGrahi is creating category-shaping innovation in the food and agri-tech pace,” said Shruti Srivastava, Investment Director at Avaana Capital. “Their proprietary insect biotechnology and bioprocessing platform enables the production of high-performance, cost-efficient ingredients at scale — helping build resilient food supply chains for global food security through science-backed, market-ready solutions.”
“We’re excited to double down on our investment in GreenGrahi as they lead India’s journey in the insect bio manufacturing industry. The timing is right, the demand is real, and India needed a bold, full-stack operator to build for both local and global markets. We’re proud to back the team as they launch the country’s first and largest BSF bio-factory, and look forward to their continued progress in market adoption and measurable impact.”, said Ishaan Khosla, Partner at Huddle Ventures
GreenGrahi’s proprietary biomanufacturing system ensures consistent quality and high conversion efficiency, enabling price points that unlock mass-market applicability, moving insect protein and biologicals beyond niche use cases.
“As wild fish stocks continue to decline and protein demand rises, the pressure on aquafeed and livestock inputs is only going to grow,” said Siddharth Sharma, Co-Founder of GreenGrahi. “We’re building a platform that makes high-quality, science-driven feed and agri-inputs accessible, affordable and scalable for global markets.”
The ₹32 crore raise will be used to build India’s largest BSF bio-factory, capable of processing 150 tonnes of feedstock daily. The company will also expand its scientific team and enter global markets, including the US, the UK and the EU. By combining cutting-edge microbiome science, bioengineering, and a strong manufacturing backbone, GreenGrahi is creating a reliable, cost-effective alternative to some of the most strained links in today’s food supply chain — from protein to crop inputs — while unlocking more value from underused agri-residues.
Published on April 24, 2025
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy.
The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making
The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution
Copyright BlazeThemes. 2023
